Logo-apb
Adv Pharm Bull. 2022;12(2): 375-382.
doi: 10.34172/apb.2022.036
PMID: 35620344
PMCID: PMC9106953
Scopus ID: 85128127740
  Abstract View: 798
  PDF Download: 418
  Full Text View: 39

Research Article

Human Bone Marrow Mesenchymal Stromal Cells Attenuate Tissue Injury and Reduce Inflammation in Experimental Acute Pancreatitis

Tayebeh Mahmoudi 1 ORCID logo, Ali Jalili 2* ORCID logo, Kamal Abdolmohammadi 3, Shohreh Fakhari 2, Fatemeh Pahlavan 1, Ali Shekari 4, Bahram Nikkhoo 2, Lobat Tayebi 5, Mohammad Reza Rahmani 2* ORCID logo

1 Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran.
2 Cancer and Immunology Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
3 Department of Immunology, School of Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran.
4 Department of Basic Sciences, Farhangian University, Sanandaj, Iran.
5 Marquette University School of Dentistry, Milwaukee, WI, 53233, USA.
*Corresponding Authors: *Corresponding Author: Ali Jalili , Email: , Email: Ali.Jalili@muk.ac.ir; *Corresponding Author: Mohammad Reza Rahmani, Email: , Email: rahmany191@gmail.com

Abstract

Purpose: Acute pancreatitis (AP) which is distinguished by local pancreatic necrosis, followingby systemic organ failure is known as an inflammatory disease. Up to now, there are only a fewtreatment options accessible for patients suffering from AP. In this study, we aimed to examinethe anti-inflammatory capacities of human bone marrow-derived mesenchymal stromal cells(hBM-MSCs) in a detailed AP model experiment.Methods: AP was induced in C57BL/6 mice by intraperitoneal administration of cerulein (100μg/kg/h × 7 doses) at intervals of 1 hour. Then, 2×105 MSCs were infused in the AP mice bytail vein 6 hours after the last cerulein injection. Mice were sacrificed 12 hours following theinjection of hBM-MSC, and blood samples and pancreas tissues were obtained.Results: We first determined the presence of transplanted hBM-MSC in the pancreas of micewith AP, but not the control mice. Our data indicate that administration of hBM-MSCs to micewith AP lead to (i) decreased serum levels of amylase, lipase and myeloperoxidase activities, (ii)downregulation of proinflammatory cytokine, macrophage inflammatory protein 2 (MIP-2), and(iii) upregulation of the anti-inflammatory cytokine, interleukin 10 (IL-10). Moreover, hBM-MSCadministration results in notably attenuated cerulein-induced histopathological alternationsand edema.Conclusion: we demonstrate that hBM-MSC attenuates AP signs and indicating that hMB-MSCtherapy could be a suitable approach for the treatment of inflammatory disease such as AP.


First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 799

Your browser does not support the canvas element.


PDF Download: 418

Your browser does not support the canvas element.


Full Text View: 39

Your browser does not support the canvas element.

Submitted: 25 May 2020
Revision: 20 Dec 2020
Accepted: 29 Jan 2021
ePublished: 31 Jan 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)